首页> 外文期刊>Journal of Hainan Medical University >Effect of recombinant human brain natriuretic peptide on serum inflammatory factors, neuroendocrine hormones and cardiac function in patients with acute myocardial infarction complicated with heart failure
【24h】

Effect of recombinant human brain natriuretic peptide on serum inflammatory factors, neuroendocrine hormones and cardiac function in patients with acute myocardial infarction complicated with heart failure

机译:重组人脑利钠肽对急性心肌梗死合并心力衰竭患者血清炎症因子,神经内分泌激素和心功能的影响

获取原文
       

摘要

Objective: To investigate the effect of recombinant human brain natriuretic peptide (BNP) oninflammatory factors, neuroendocrine hormones and cardiac function indexes in patients withacute myocardial infarction complicated with heart failure. Methods: A total of 91 cases ofacute myocardial infarction with heart failure patients were divided into the control group (n=44)and observation group (n=47) according to the random data table, two groups of patients weregiven conventional treatment, based on this, the control group was given intravenous infusionof Nitroglycerin Injection treatment, the observation group received intravenous injection ofrecombinant human brain natriuretic peptide treatment, compared serum inflammatory factors,neuroendocrine hormone and cardiac function and other indexes of two groups before andafter treatment. Results: there was no significant difference between the two groups beforetreatment. After treatment, the levels of TNF-α, hs-CRP, IL-6, MCP-1, LVESD and LVEDDin the two groups were significantly lower than those within the group before treatment, andthe observation group was significantly lower than the control group; The two groups aftertreatment LVEF levels were significantly higher than those in the group before treatment, andthe observation group was significantly higher than that of control group; the observation groupafter treatment PRA, Ang II and ALD and NE levels were significantly lower than those beforetreatment, and was significantly lower than the control group after treatment, the differencewas significant, PRA, Ang, ALD and NE levels of control group before and after the treatmentwas no significant difference. Conclusion: recombinant human brain natriuretic peptide inthe treatment of acute myocardial infarction with heart failure can effectively reduce the seruminflammatory factors and neuroendocrine hormone levels, improve heart function, and have acertain clinical value.
机译:目的:探讨重组人脑利钠肽(BNP)对急性心肌梗死合并心力衰竭患者炎症因子,神经内分泌激素和心功能指标的影响。方法:根据随机数据表,将91例急性心力衰竭合并心力衰竭的患者分为对照组(n = 44)和观察组(n = 47),对两组患者进行常规治疗。为此,对照组给予硝酸甘油静脉注射治疗,观察组接受重组人脑利钠肽静脉注射治疗,比较两组治疗前后血清炎症因子,神经内分泌激素和心功能等指标。结果:两组治疗前无明显差异。治疗后,两组患者的TNF-α,hs-CRP,IL-6,MCP-1,LVESD和LVEDD水平均明显低于治疗前组,观察组明显低于对照组。两组治疗后LVEF水平明显高于治疗前组,观察组明显高于对照组。观察组治疗后PRA,Ang II,ALD,NE水平明显低于治疗前,且治疗后明显低于对照组,差异有统计学意义。治疗无明显差异。结论:重组人脑利钠肽治疗急性心肌梗死合并心力衰竭可有效降低血清炎症因子和神经内分泌激素水平,改善心功能,具有一定的临床价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号